These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 34576273)
1. Metabolic and Lipidomic Assessment of Kidney Cells Exposed to Nephrotoxic Vancomycin Dosages. Lagies S; Pichler R; Vladimirov G; Gawron J; Bäzner F; Schreiner A; Kadena D; Plattner DA; Lienkamp SS; Kammerer B Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576273 [TBL] [Abstract][Full Text] [Related]
2. Urinary metabolomics study of vancomycin-associated nephrotoxicity based on ultra-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. Cao P; Kang Y; Liu J; Liu X; Jin Y; Zhang Z Hum Exp Toxicol; 2022; 41():9603271221119178. PubMed ID: 35984423 [TBL] [Abstract][Full Text] [Related]
3. In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455. Yarlagadda V; Konai MM; Manjunath GB; Prakash RG; Mani B; Paramanandham K; Ranjan SB; Ravikumar R; Chakraborty SP; Roy S; Haldar J Int J Antimicrob Agents; 2015 Jun; 45(6):627-34. PubMed ID: 25900818 [TBL] [Abstract][Full Text] [Related]
4. New insights into the vancomycin-induced nephrotoxicity using in vitro metabolomics combined with physiologically based pharmacokinetic modeling. Du H; Li Z; Yang Y; Li X; Wei Y; Lin Y; Zhuang X J Appl Toxicol; 2020 Jul; 40(7):897-907. PubMed ID: 32079046 [TBL] [Abstract][Full Text] [Related]
5. Novel two-chain fatty acid-based lipids for development of vancomycin pH-responsive liposomes against Makhathini SS; Kalhapure RS; Jadhav M; Waddad AY; Gannimani R; Omolo CA; Rambharose S; Mocktar C; Govender T J Drug Target; 2019 Dec; 27(10):1094-1107. PubMed ID: 30901236 [TBL] [Abstract][Full Text] [Related]
6. High-Dose Vitamin C Preadministration Reduces Vancomycin-Associated Nephrotoxicity in Mice. Takigawa M; Yatsu T; Takino Y; Matsumoto S; Kitano T; Lee J; Arai T; Tanaka H; Ishii T; Mori Y; Ishigami A J Nutr Sci Vitaminol (Tokyo); 2019; 65(5):399-404. PubMed ID: 31666476 [TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model. Hegde SS; Okusanya OO; Skinner R; Shaw JP; Obedencio G; Ambrose PG; Blais J; Bhavnani SM Antimicrob Agents Chemother; 2012 Mar; 56(3):1578-83. PubMed ID: 22155835 [TBL] [Abstract][Full Text] [Related]
8. Establishment of an AUC Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672 [TBL] [Abstract][Full Text] [Related]
13. Empiric weight-based vancomycin in intensive care unit patients with methicillin-resistant Staphylococcus aureus bacteremia. Alvarez CA; Giuliano CA; Haase KK; Thompson KA; Frei CR; Forcade NA; Brouse SD; Mortensen EM; Bell T; Bedimo RJ; Toups NM; Hall RG Am J Med Sci; 2014 Nov; 348(5):371-6. PubMed ID: 24762747 [TBL] [Abstract][Full Text] [Related]
14. Toxicity Profile and Pharmacokinetic Study of Antibiotic Mixtures, Gentamicin and Vancomycin, in Rat Plasma by Ecofriendly Liquid Chromatography Coupled Tandem Mass Spectrometry. Ibrahim F; Elgawish MS; Mehana E; El-Adl SM; Baraka MM; Ibrahim SM; Sebaiy MM Chem Res Toxicol; 2020 Oct; 33(10):2647-2658. PubMed ID: 32940458 [TBL] [Abstract][Full Text] [Related]
15. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia. Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357 [TBL] [Abstract][Full Text] [Related]
16. Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus. Haste NM; Thienphrapa W; Tran DN; Loesgen S; Sun P; Nam SJ; Jensen PR; Fenical W; Sakoulas G; Nizet V; Hensler ME J Antibiot (Tokyo); 2012 Dec; 65(12):593-8. PubMed ID: 23047246 [TBL] [Abstract][Full Text] [Related]
17. Teicoplanin versus vancomycin for proven or suspected infection. Cavalcanti AB; Goncalves AR; Almeida CS; Bugano DD; Silva E Cochrane Database Syst Rev; 2010 Jun; (6):CD007022. PubMed ID: 20556772 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat. Nishino Y; Takemura S; Minamiyama Y; Hirohashi K; Tanaka H; Inoue M; Okada S; Kinoshita H Redox Rep; 2002; 7(5):317-9. PubMed ID: 12688519 [TBL] [Abstract][Full Text] [Related]
19. Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus. Fernandez J; Abbanat D; Shang W; He W; Amsler K; Hastings J; Queenan AM; Melton JL; Barron AM; Flamm RK; Lynch AS Antimicrob Agents Chemother; 2012 Mar; 56(3):1476-84. PubMed ID: 22232278 [TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections. Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]